Our Cell & Gene Therapy division has implemented a risk-based, precision-driven logistics model that leverages multimodal solutions to ensure the safe, timely, and fully compliant delivery of advanced therapies across Europe.
Because these therapies are living, high-value, and irreplaceable, our approach guarantees total traceability and zero margin for error at every stage of the logistics process.
Mulder Express is a Dutch company specializing in 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗱𝗶𝘀𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗼𝗻, and this strategic acquisition further strengthens the 𝗣𝗛𝗦𝗘 𝗚𝗿𝗼𝘂𝗽’𝘀 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗮𝗻𝗱 𝗴𝗹𝗼𝗯𝗮𝗹 𝗳𝗼𝗼𝘁𝗽𝗿𝗶𝗻𝘁.
As part of this expansion, PHSE will also open a 𝗻𝗲𝘄 𝘄𝗮𝗿𝗲𝗵𝗼𝘂𝘀𝗲 𝗻𝗲𝗮𝗿 𝗦𝗰𝗵𝗶𝗽𝗵𝗼𝗹 𝗔𝗶𝗿𝗽𝗼𝗿𝘁 at the beginning of October, reinforcing its presence in one of Europe’s most strategic logistics hubs.
New Orleans, June 21–24, 2025
We’re proud to announce that PHSE will be exhibiting at the upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2025, a premier event in the field of nuclear medicine and molecular imaging.
As a global leader in radiopharmaceutical logistics, PHSE is committed to supporting innovation in advanced diagnostic and therapeutic solutions.
Why visit us:
– Learn how we ensure end-to-end safety in radiopharma cold chain
– Discover logistics strategies that accelerate patient access
– Explore tailored solutions for the nuclear medicine ecosystem
Join us at Booth 1137 to meet our team
Messe München, June 2–5, 2025
PHSE is pleased to announce its participation in Transport Logistic 2025, the world’s leading trade fair for logistics, mobility, IT, and supply chain management.
This international platform is the ideal opportunity to showcase our healthcare logistics expertise and cold chain capabilities. Our team will be there to discuss:
– Temperature-controlled transport for pharmaceutical products
– Customized logistics services aligned with GDP standards
– PHSE’s role in powering global healthcare supply chains
We are pleased to announce PHSE’s participation in CPHI China 2025, one of the leading global pharmaceutical events in Asia.
From June 24 to 26, 2025, our representatives will be at the Shanghai New International Expo Centre (SNIEC) to meet with partners, clients, and industry professionals.
For PHSE, CPHI China is a key opportunity to strengthen our international network and further establish our role as a trusted logistics partner in the pharma world.
Milan, 09 May 2025
PHSE, a leading global group in temperature-controlled and time critical pharmaceutical logistics, announces that today it has completed the acquisition of 100% of Sat Cargo Srl, a company specialized in international (import and export) temperature-controlled transport of pharmaceuticals, animal healths products and food supplements, with storage and “cross docking” activities at its temperature-controlled warehouse in Lainate (MI), operating at +2/+8 °C and +15/+25 °C and covering approximately 5,000 sqm.
This transaction represents a strategic step for PHSE in strengthening its position in the “Pharma and Healthcare” global forwarding segment, one of the Group’s main development directions, alongside the growth in the radiopharmaceutical sector.
Sat Cargo’s deep expertise in international transport, carried out mainly by air and sea, fits perfectly with PHSE’s operations and will benefit from the strength of the Group’s international network, currently present in 9 countries.
PHSE expects to reach consolidated revenues of €120–130 million in 2025, further strengthening its leadership in the sector
HSE is attending LogiPharma 2025, the world’s leading life sciences supply chain event.
This year’s edition celebrates 25 years as the voice of the industry, bringing together key leaders from the pharmaceutical and MedTech supply chains to address current challenges and embrace new opportunities.
We are at booth 63, where our team meets with clients, partners, and industry professionals to share our expertise and innovative solutions in temperature-controlled pharmaceutical logistics.
At LogiPharma 2025, we explore the future of the pharma supply chain together.